Benchmark Boosts Ultralife (NASDAQ:ULBI) Price Target to $14.00

Ultralife (NASDAQ:ULBI) had its price target increased by Benchmark from $13.00 to $14.00 in a research report report published on Thursday, Benzinga reports. Benchmark currently has a buy rating on the technology company’s stock.

Separately, StockNews.com downgraded Ultralife from a strong-buy rating to a buy rating in a research report on Thursday, May 2nd.

Ultralife Trading Up 2.5 %

Shares of NASDAQ:ULBI opened at $10.62 on Thursday. The company has a market capitalization of $176.53 million, a P/E ratio of 16.59 and a beta of 0.99. Ultralife has a 1 year low of $4.61 and a 1 year high of $13.39. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.03 and a quick ratio of 2.16. The business’s 50 day simple moving average is $11.11 and its 200 day simple moving average is $9.17.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings results on Thursday, April 25th. The technology company reported $0.21 earnings per share (EPS) for the quarter. The business had revenue of $41.93 million for the quarter. Ultralife had a return on equity of 10.31% and a net margin of 6.19%.

Institutional Investors Weigh In On Ultralife

Large investors have recently modified their holdings of the business. Visionary Wealth Advisors boosted its holdings in shares of Ultralife by 0.9% in the 4th quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock valued at $7,381,000 after purchasing an additional 9,997 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in shares of Ultralife in the 3rd quarter valued at $1,039,000. Citigroup Inc. bought a new position in shares of Ultralife in the 3rd quarter valued at $74,000. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Ultralife in the 3rd quarter valued at $36,000. Finally, Pitti Group Wealth Management LLC lifted its stake in shares of Ultralife by 41.3% in the 4th quarter. Pitti Group Wealth Management LLC now owns 18,120 shares of the technology company’s stock valued at $124,000 after acquiring an additional 5,300 shares during the last quarter. Institutional investors and hedge funds own 30.68% of the company’s stock.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.